Immediate Impact

1 by Nobel laureates 10 from Science/Nature 70 standout
Sub-graph 1 of 23

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
3 intermediate papers

Works of Terry Katz being referenced

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma
2011
A phase II multicenter study of cetuximab monotherapy in patients with EGFR-undetectable refractory metastatic colorectal carcinoma (mCRC)
2008

Author Peers

Author Last Decade Papers Cites
Terry Katz 210 151 170 31 647
H. Weiler 72 123 140 29 731
Kikumi OGIHARA 73 143 164 62 525
Thomas G. Bell 35 145 143 45 726
S.A. Benjamin 81 267 100 36 672
Fumio Kinoshita 110 117 177 42 589
Yoshimune Horibe 238 114 119 32 629
Deepu Alex 188 237 212 29 732
Wenkui Sun 60 175 110 50 665
K. Katagiri 59 59 123 60 624
W Ogunkolade 75 39 227 23 547

All Works

Loading papers...

Rankless by CCL
2026